Muscarinic cholinergic receptors in the atria mediate the regulation of the heart by the parasympathetic nervous systems. In order to obtain detailed information regarding the molecular mechanism of atrial muscarinic receptor signal transduction two approaches are proposed. The first is to use site- directed mutagenesis to explore the roles of specific amino acids in ligand binding, thermal stability and coupling to either endogenous Chinese Hamster ovary (CHO) cell G proteins or to atrial Gi reconstituted into CHO cell membranes. The second approach is to use biophysical methods such as circular dichroism and transient kinetics to examine changes in secondary structure that occur when ligands bind to the purified recombinant protein or to detect and analyze protein conformational changes that occur in the membrane-bound or purified preparations. Interaction of defined Gialpha1,2,3, with atrial Gibetagamma and muscarinic receptors, by resolving purified atrial gi into gil and Gi3 or by purifying Gi1,2,3 from brain and erythrocytes. The detailed knowledge of muscarinic mechanisms in the heart may be useful in the rational design of drugs for use in treating cardiac arrhymias as tachycardia.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
2R01HL023632-12
Application #
3337339
Study Section
Pharmacology A Study Section (PHRA)
Project Start
1980-12-01
Project End
1995-06-30
Budget Start
1991-07-01
Budget End
1992-06-30
Support Year
12
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Oregon State University
Department
Type
Schools of Arts and Sciences
DUNS #
053599908
City
Corvallis
State
OR
Country
United States
Zip Code
97339
Mosser, Valerie A; Amana, Ian J; Schimerlik, Michael I (2002) Kinetic analysis of M2 muscarinic receptor activation of Gi in Sf9 insect cell membranes. J Biol Chem 277:922-31
Vogel, W K; Peterson, G L; Broderick, D J et al. (1999) Double mutant cycle analysis of aspartate 69, 97, and 103 to asparagine mutants in the m2 muscarinic acetylcholine receptor. Arch Biochem Biophys 361:283-94
Vogel, W K; Sheehan, D M; Schimerlik, M I (1997) Site-directed mutagenesis on the m2 muscarinic acetylcholine receptor: the significance of Tyr403 in the binding of agonists and functional coupling. Mol Pharmacol 52:1087-94
Bulseco, D A; Schimerlik, M I (1996) Single amino acid substitutions in the pm2 muscarinic receptor alter receptor/G protein coupling without changing physiological responses. Mol Pharmacol 49:132-41
Vogel, W K; Mosser, V A; Bulseco, D A et al. (1995) Porcine m2 muscarinic acetylcholine receptor-effector coupling in Chinese hamster ovary cells. J Biol Chem 270:15485-93
Hirschberg, B T; Mosser, V A; Peterson, G L et al. (1995) Kinetic and biophysical analysis of the m2 muscarinic receptor. Life Sci 56:907-13
Peterson, G L; Toumadje, A; Johnson Jr, W C et al. (1995) Purification of recombinant porcine m2 muscarinic acetylcholine receptor from Chinese hamster ovary cells. Circular dichroism spectra and ligand binding properties. J Biol Chem 270:17808-14
Huang, S C; Fortune, K P; Wank, S A et al. (1994) Multiple affinity states of different cholecystokinin receptors. J Biol Chem 269:26121-6
Tota, M R; Schimerlik, M I (1990) Partial agonist effects on the interaction between the atrial muscarinic receptor and the inhibitory guanine nucleotide-binding protein in a reconstituted system. Mol Pharmacol 37:996-1004
Tota, M R; Xia, Z Q; Storm, D R et al. (1990) Reconstitution of muscarinic receptor-mediated inhibition of adenylyl cyclase. Mol Pharmacol 37:950-7

Showing the most recent 10 out of 20 publications